ADRB2 and heart failure: Combined use of β1-AR blocker and β2-AR agonist has been proposed to treat chronic heart failure [6], and they have demonstrated improved cardiac function in rats with heart failure, ventricular remodeling, and myocardial apoptosis [7, 8].